Tagged with Ipsen,

Ipsen’s Aggressive M&A Strategy Pays Off with “New Era of Dynamic Growth”
French Pharma in 2024: 5 Things to Know
France: Industry Demands Easing of Paybacks as Country Bids for Medicine Sovereignty
Long Read: Greece – Back on Track?
Clinical Trials in Greece: Small Steps Forward
George Carystinos – General Manager Greece, Cyprus & Israel, Ipsen
Greece’s EU Recovery Funds: Unlocking Potential in Manufacturing, Primary Care & Digitalisation
Egypt: ‘A Key Opportunity’ for MEA General Managers
Why Pharma Multinationals Continue to Invest in Irish Manufacturing
Five Country Managers on Overcoming Italy’s Market Access Complexities
Ipsen Continues M&A Push with Acquisition of Epizyme
Stephane Brocker – Country President, Managing Director Italy, Ipsen
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here